These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1361821

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Renal osteodystrophy in patients on hemodialysis for more than 10 years.
    Piraino BM, Rault R, Dominguez JH, Puschett JB.
    Miner Electrolyte Metab; 1986; 12(5-6):390-6. PubMed ID: 3807834
    [Abstract] [Full Text] [Related]

  • 48. Renal bone disease in pediatric patients receiving treatment with maintenance peritoneal dialysis.
    Salusky IB, Goodman WG.
    Child Nephrol Urol; 1991; 11(3):165-8. PubMed ID: 1777895
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Aluminum bone content in dialysis osteodystrophy with secondary hyperparathyroidism.
    Pizzarelli F, Ballanti P, Costantini S, Mocetti P, Giordano R, Della Rocca C, Fabrizi F, Bonucci E, Maggiore Q.
    Miner Electrolyte Metab; 1988; 14(2-3):129-34. PubMed ID: 3380068
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Different patterns of renal osteodystrophy in Iberoamerica.
    Jorgetti V, López BD, Caorsi H, Ferreira A, Palma A, Menendez P, Douthat W, Olaizola I, Ribeiro S, Jarava C, Moreira E, Cannata J.
    Am J Med Sci; 2000 Aug; 320(2):76-80. PubMed ID: 10981479
    [Abstract] [Full Text] [Related]

  • 54. Calcium salts of keto-amino acids, a phosphate binder alternative for patients on CAPD.
    Macia M, Coronel F, Navarro JF, Gallego E, Herrero JA, Méndez ML, Chahin J, García J.
    Clin Nephrol; 1997 Sep; 48(3):181-4. PubMed ID: 9342490
    [Abstract] [Full Text] [Related]

  • 55. [The impact of low calcium dialysate (1.25 mmol/l; LCD) on bone metabolism in CAPD patients].
    Terawaki H, Kasai K, Kawaguchi Y, Kobayashi H, Hirano K, Ohtsuka Y, Hosoya T.
    Nihon Jinzo Gakkai Shi; 1998 May; 40(4):252-7. PubMed ID: 9654908
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Risk factors for renal osteodystrophy: a multivariant analysis.
    Pei Y, Hercz G, Greenwood C, Segre G, Manuel A, Saiphoo C, Fenton S, Sherrard D.
    J Bone Miner Res; 1995 Jan; 10(1):149-56. PubMed ID: 7747622
    [Abstract] [Full Text] [Related]

  • 58. The localization of aluminium and other elements in bone tissue of a case of renal osteodystrophy with an associated dialysis encephalopathy syndrome.
    McClure J, Smith PS.
    J Pathol; 1984 Apr; 142(4):293-9. PubMed ID: 6716213
    [Abstract] [Full Text] [Related]

  • 59. Bone aluminum deposition in maintenance dialysis patients treated with aluminium-free dialysate: role of aluminium hydroxide consumption.
    Heaf JG, Pødenphant J, Andersen JR.
    Nephron; 1986 Apr; 42(3):210-6. PubMed ID: 3945361
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.